An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry.

: This study suggests that CBMPs are associated with an improvement in health-related quality of life in UK patients with chronic diseases. Treatment was tolerated well by most participants, but adverse events were more common in female and cannabis-naïve patients.